Texas Digestive Disease Consultants - San Marcos
San Marcos, Texas, United States
Medical clinic in San Marcos, Texas
1305 Wonder World Dr Ste 200, San Marcos, TX 78666
About Texas Digestive Disease Consultants - San Marcos
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
3
Gilead Sciences
3
Madrigal Pharmaceuticals, Inc.
3
Arena Pharmaceuticals
2
Intercept Pharmaceuticals
2
Genentech, Inc.
1
Pfizer
1
Clinical Trials at Texas Digestive Disease Consultants - San Marcos
During the past decade, Texas Digestive Disease Consultants - San Marcos conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
2015-09-22
2025-09-01
Active, not recruiting
2,480
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
2016-11-14
2020-03-31
Completed
1,351
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
2017-02-23
2026-09-01
Active, not recruiting
1,173
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
2017-03-17
2025-01-01
Enrolling by invitation
1,000
Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
2017-04-11
2020-07-20
Completed
78
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
2017-08-30
2022-09-08
Completed
919
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
2019-03-28
2026-05-01
Recruiting
2,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texas Digestive Disease Consultants - San Marcos" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 3 trials
sponsored, "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Intercept Pharmaceuticals"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Digestive Disease Consultants - San Marcos"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Texas Digestive Disease Consultants - San Marcos
According to Clinical.Site data, the most researched conditions in "Texas Digestive Disease Consultants - San Marcos" are
"Ulcerative Colitis" (6 trials), "Crohn's Disease" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials), "Compensated Cirrhosis" (1 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Texas Digestive Disease Consultants - San Marcos" in a lesser frequency.
Clinical Trials Intervention Types at Texas Digestive Disease Consultants - San Marcos
Most popular intervention types in "Texas Digestive Disease Consultants - San Marcos" are "Drug" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (5 trials), "Etrasimod" (3 trials), "Placebo to match filgotinib" (2 trials) and "Resmetirom" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Digestive Disease Consultants - San Marcos
The vast majority of trials in "Texas Digestive Disease Consultants - San Marcos" are
15 trials for "All" genders.
Clinical Trials Status at Texas Digestive Disease Consultants - San Marcos
Currently, there are NaN active trials in "Texas Digestive Disease Consultants - San Marcos".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 7 completed trials in Texas Digestive Disease Consultants - San Marcos,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Digestive Disease Consultants - San Marcos, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".